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We have read with interest three related papers that were recently published in this journal.1-3 
Taken together, the findings reported in these papers (summarized in online supplementary 
note) suggest that loss-of-function PRSS1 promoter variants can protect against pancreatitis. 
The other side of the coin is however that gain-of-function PRSS1 promoter variants 
predispose to pancreatitis. It therefore follows that the risk-associated [rs4726576C; 
rs10273639C] allele shares a common pathogenetic mechanism with the previously reported 
trypsinogen duplication and triplication copy number variants (CNVs)4,5 since both types of 
variant predispose to pancreatitis by increasing PRSS1 expression; this mechanism is quite 
distinct from either the increased activation and/or stability of trypsin(ogen) or misfolding-
induced endoplasmic reticulum stress caused by disease-associated PRSS1 missense 
mutations.6 However, despite both serving to increase PRSS1 expression, the promoter 
variant and the CNVs differ significantly in terms of the relative strength of their genetic 
effects. The risk-associated [rs4726576C; rs10273639C] allele (whose frequency was found 
to be 0.54 and 0.57 respectively in healthy French individuals of European ancestry3 and 
controls from the North American Pancreatitis Study 27) had only a modest genetic effect, 
defined as having an Odds Ratio of <1.5 in accordance with ref. 8, with respect to the clinical 
phenotype. By contrast, the PRSS1 duplication/triplication CNVs, which have never been 
reported in normal populations, can be classified as disease-causative. 
Despite their evident clinical importance, PRSS1 CNVs have not so far been analysed by 
many research groups. Apart from the technical difficulties inherent in detecting CNVs, 
particularly those characterized by an increased copy number, there may be another reason 
viz. the PRSS1 duplication and triplication CNVs found in French Caucasian patients with 
hereditary, familial or sporadic chronic pancreatitis4,5 arose from a common founder 
chromosome.9 However, a PRSS1 CNV was also identified in one of 75 Chinese children 
with idiopathic chronic pancreatitis.10 Although the breakpoints of this CNV have not yet 
been characterized, the Chinese data provided the first evidence that pathogenic PRSS1 
CNVs have more than one independent origin. Indeed, during our routine screening of young 
French patients with chronic pancreatitis or acute recurrent pancreatitis (see methods in 
online supplementary note), we identified and characterized four novel and non-identical 
PRSS1 duplication CNVs (figure 1): #2 in a Caucasian patient with a family history of the 
disease; #3 in a Maghrebian patient with sporadic pancreatitis; #4 in a Caucasian patient plus 
two family members (brother and father); and #5 in a sporadic pancreatitis patient from 
French Guiana. Not surprisingly, all four novel duplication CNVs involved the entire PRSS1 
gene, as well as the entire anionic trypsinogen (PRSS2) gene.  
In summary, the recent publications on common PRSS1 promoter variants1-3 and the 
ongoing discovery of rare PRSS1 CNVs serve to emphasize the key role of increased PRSS1 
expression in the aetiology of pancreatitis. Our new findings demonstrating multiple 
independent origins for PRSS1 CNVs, taken together with the earlier Chinese findings10, 
suggest that, irrespective of their ethnogeographic origin, PRSS1 CNVs could be present in 
those pancreatitis patients in whom a genetic risk factor has not yet been identified. Routine 
screening for this important type of disease-causing variant is therefore warranted in 
pancreatitis.   
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Figure legend 
Figure 1  Schematic illustration of the PRSS1 (as well as PRSS2) duplication CNVs whose 
breakpoints have been characterized at the nucleotide sequence level. The start and end 
positions of each duplicated segment are indicated in accordance with human GRCh38/hg38. 
The critical region contained within these duplicated sequences is indicated by vertical dotted 
lines. Whereas #3, #4 and #5 are simple duplications, #1 and #2 are complex duplications. In 
#1, only the functionally relevant duplicated segment is shown; this duplicated allele gave 
rise to the previously known triplication allele.9 In #2, an insertion was present in the aberrant 
chromosomal junction. Sequences spanning the aberrant chromosomal junctions of the four 
novel PRSS1 duplication CNVs are provided in supplementary figure S1. 
 
